Pg. Coulie et al., GENES-CODING FOR TUMOR-ANTIGENS RECOGNIZED BY HUMAN CYTOLYTIC T-LYMPHOCYTES, Journal of immunotherapy with emphasis on tumor immunology, 14(2), 1993, pp. 104-109
Citations number
28
Categorie Soggetti
Immunology,Oncology,"Medicine, Research & Experimental
In order to define the antigens recognized by cytolytic T lymphocytes
(CTLs) on autologous tumors, we derived tumor-specific CTL clones from
autologous mixed lymphocyte tumor cell cultures. The gene coding for
a tumor rejection antigen expressed on a melanoma was isolated by tran
sfecting genomic DNA of the tumor into an antigen-loss variant of the
melanoma. Transfectants were identified on the basis of their ability
to stimulate tumor necrosis factor release by the CTL clone. The gene
that transferred the expression of the antigen was named MAGE-1. It is
a new gene, silent in normal tissues with the exception of testis, bu
t expressed in several types of tumors. The antigen recognized by the
CTL clone is a nonapeptide derived from the protein encoded by gene MA
GE-1, and presented by the HLA class I molecule HLA-A1. Using two othe
r antimelanoma CTL clones, we identified the tyrosinase gene as coding
for an antigen presented by HLA-A2 on this type of tumors. The identi
fication of these tumor rejection antigens open new possibilities for
the specific immunotherapy of cancer.